Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure
Martin St John Sutton, Stefano Ghio, Ted Plappert, Luigi Tavazzi, Laura Scelsi, Claude Daubert, William T Abraham, Michael R Gold, Christian Hassager, John M Herre, Cecilia Linde, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group, Martin St John Sutton, Stefano Ghio, Ted Plappert, Luigi Tavazzi, Laura Scelsi, Claude Daubert, William T Abraham, Michael R Gold, Christian Hassager, John M Herre, Cecilia Linde, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group
Abstract
Background: Cardiac resynchronization therapy (CRT) improves LV structure, function, and clinical outcomes in New York Heart Association class III/IV heart failure with prolonged QRS. It is not known whether patients with New York Heart Association class I/II systolic heart failure exhibit left ventricular (LV) reverse remodeling with CRT or whether reverse remodeling is modified by the cause of heart failure.
Methods and results: Six hundred ten patients with New York Heart Association class I/II heart failure, QRS duration > or =120 ms, LV end-diastolic dimension > or =55 mm, and LV ejection fraction < or =40% were randomized to active therapy (CRT on; n=419) or control (CRT off; n=191) for 12 months. Doppler echocardiograms were recorded at baseline, before hospital discharge, and at 6 and 12 months. When CRT was turned on initially, immediate changes occurred in LV volumes and ejection fraction; however, these changes did not correlate with the long-term changes (12 months) in LV end-systolic (r=0.11, P=0.31) or end-diastolic (r=0.10, P=0.38) volume indexes or LV ejection fraction (r=0.07, P=0.72). LV end-diastolic and end-systolic volume indexes decreased in patients with CRT turned on (both P<0.001 compared with CRT off), whereas LV ejection fraction in CRT-on patients increased (P<0.0001 compared with CRT off) from baseline through 12 months. LV mass, mitral regurgitation, and LV diastolic function did not change in either group by 12 months; however, there was a 3-fold greater reduction in LV end-diastolic and end-systolic volume indexes and a 3-fold greater increase in LV ejection fraction in patients with nonischemic causes of heart failure.
Conclusions: CRT in patients with New York Heart Association I/II resulted in major structural and functional reverse remodeling at 1 year, with the greatest changes occurring in patients with a nonischemic cause of heart failure. CRT may interrupt the natural disease progression in these patients. Clinical Trial Registration- Clinicaltrials.gov Identifier: NCT00271154.
Source: PubMed